{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:47:41Z","timestamp":1782823661456,"version":"3.54.5"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJNPH"],"accepted":{"date-parts":[[2026,1,7]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-diabetes is a well-known risk factor for diabetes, a major contributor to morbidity and mortality globally. Identifying patients at highest risk of developing diabetes facilitates early intervention. There is no consensus on diagnostic criteria, with no single modality or range shown to be most predictive of progression to diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis aimed to determine which single or combination biochemical test(s) and definition of pre-diabetes best predict progression to diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following primary screening of 11 980 papers from MEDLINE, Embase and Global Health, 40 original studies published between 2006 and 2024 looking at adults with pre-diabetes were included. Children, pregnant patient populations and groups with significant morbidity were excluded. Risk of bias was assessed with the JBI Critical Appraisal Checklist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our meta-analysis demonstrated the highest risk of progression to diabetes in the impaired fasting glucose (IFG) 6.1\u20136.9 mmol\/L group, with an HR of 9.0 (4.6 to 13.5). Descriptive statistics identified the combination of IFG 6.1\u20136.9 mmol\/L + impaired glucose tolerance + HbA1c 6.0%\u20136.4% had the highest percent incidence of diabetes per year, at 15.2%. Generally, combination tests were associated with higher progression rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Certain single and combination biochemical test combinations may allow better identification of patients with pre-diabetes likely to progress to diabetes. To our knowledge, this is the first systematic review evaluating all testing combinations of these categories in progression and comparing pre-diabetes states as defined by multiple guidelines. This study (PROSPERO CRD42022312640) did not receive funding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjnph-2024-000877","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:35:15Z","timestamp":1770651315000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting pre-diabetes progression: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-0474","authenticated-orcid":false,"given":"Kate","family":"Meads","sequence":"first","affiliation":[{"name":"The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Machiraju","sequence":"additional","affiliation":[{"name":"The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Shi","sequence":"additional","affiliation":[{"name":"The University of Sydney Charles Perkins Centre, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Colagiuri","sequence":"additional","affiliation":[{"name":"Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026063004402422000_9.1.240.1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"The Lancet"},{"key":"2026063004402422000_9.1.240.2","unstructured":"International Diabetes Federation . IDF diabetes atlas. Brussels, Belgium. 2025."},{"key":"2026063004402422000_9.1.240.3","unstructured":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva World Health Organization; 2006."},{"key":"2026063004402422000_9.1.240.4","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002"},{"key":"2026063004402422000_9.1.240.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9033"},{"key":"2026063004402422000_9.1.240.6","unstructured":"JBI . Checklist for cohort studies. Adelaide JBI Global; 2020."},{"key":"2026063004402422000_9.1.240.7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.35755\/jmedassocthai.2021.05.12099","article-title":"Progression of Prediabetes to Type 2 Diabetes Mellitus in Thai Population","volume":"104","author":"Wutthisathapornchai","year":"2021","journal-title":"J Med Assoc Thai"},{"key":"2026063004402422000_9.1.240.8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-019-4895-0","article-title":"Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study","volume":"62","author":"Vistisen","year":"2019","journal-title":"Diabetologia"},{"key":"2026063004402422000_9.1.240.9","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0227"},{"key":"2026063004402422000_9.1.240.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002427","article-title":"Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose","volume":"9","author":"Thamakaison","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026063004402422000_9.1.240.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-011-9619-9"},{"key":"2026063004402422000_9.1.240.12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamainternmed.2020.8774","article-title":"Risk of Progression to Diabetes Among Older Adults With Prediabetes","volume":"181","author":"Rooney","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2026063004402422000_9.1.240.13","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1392"},{"key":"2026063004402422000_9.1.240.14","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2147\/DMSO.S307456","article-title":"Nomogram Predicting the Risk of Progression from Prediabetes to Diabetes After a 3-Year Follow-Up in Chinese Adults","volume":"14","author":"Liang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2026063004402422000_9.1.240.15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diabres.2014.08.014","article-title":"Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes","volume":"106","author":"Kim","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.diabres.2016.06.009","article-title":"Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans","volume":"118","author":"Kim","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2016.10.004","article-title":"Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study","volume":"123","author":"Han","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033332","article-title":"Prevalence of pre-diabetes and undiagnosed diabetes in the Mollerussa prospective observational cohort study in a semi-rural area of Catalonia","volume":"10","author":"Falguera","year":"2020","journal-title":"BMJ Open"},{"key":"2026063004402422000_9.1.240.19","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051538","article-title":"Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes","volume":"12","author":"Bennasar-Veny","year":"2020","journal-title":"Nutrients"},{"key":"2026063004402422000_9.1.240.20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diabres.2011.05.028","article-title":"Optimal range of HbA1c for the prediction of future diabetes: a 4-year longitudinal study","volume":"93","author":"Bae","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.21","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1084"},{"key":"2026063004402422000_9.1.240.22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3803\/EnM.2020.798","article-title":"Predictive Performance of Glycated Hemoglobin for Incident Diabetes Compared with Glucose Tolerance Test According to Central Obesity","volume":"35","author":"Yoo","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2026063004402422000_9.1.240.23","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1390"},{"key":"2026063004402422000_9.1.240.24","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2631"},{"key":"2026063004402422000_9.1.240.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60472-8"},{"key":"2026063004402422000_9.1.240.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2814"},{"key":"2026063004402422000_9.1.240.27","doi-asserted-by":"crossref","first-page":"111119","DOI":"10.1016\/j.diabres.2024.111119","article-title":"Incidence of T2DM and the role of baseline glycaemic status as a determinant in a metropolitan population in northern Madrid (Spain)","volume":"209","author":"Iriarte-Campo","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.28","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab222","article-title":"Risk of progression to diabetes and mortality in older people with prediabetes: The English longitudinal study on ageing","volume":"51","author":"Veronese","year":"2022","journal-title":"Age Ageing"},{"key":"2026063004402422000_9.1.240.29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/pds.4007","article-title":"Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD)","volume":"25","author":"Hong","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026063004402422000_9.1.240.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2461"},{"key":"2026063004402422000_9.1.240.31","first-page":"453","article-title":"Glucose metabolism among residents in Shanghai: natural outcome of a 5-year follow-up study","volume":"35","author":"Qian","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2026063004402422000_9.1.240.32","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0912"},{"key":"2026063004402422000_9.1.240.33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2169\/internalmedicine.54.2839","article-title":"Utility of 75-g Oral Glucose Tolerance Test Results and Hemoglobin A1c Values for Predicting the Incidence of Diabetes Mellitus among Middle-aged Japanese Men -A Large-scale Retrospective Cohort Study Performed at a Single Hospital-","volume":"54","author":"Fujibayashi","year":"2015","journal-title":"Intern Med"},{"key":"2026063004402422000_9.1.240.34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1753-0407.2011.00169.x","article-title":"Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: a study using the National Healthcare Group Diabetes Registry in Singapore","volume":"4","author":"Ang","year":"2012","journal-title":"J Diabetes"},{"key":"2026063004402422000_9.1.240.35","doi-asserted-by":"crossref","first-page":"109193","DOI":"10.1016\/j.diabres.2022.109193","article-title":"Factors associated with progression of different prediabetic status to Diabetes: A Community-based cohort study","volume":"184","author":"Li","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.metabol.2007.10.017","article-title":"Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study","volume":"57","author":"Vald\u00e9s","year":"2008","journal-title":"Metab Clin Exp"},{"key":"2026063004402422000_9.1.240.37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(19)30058-0","article-title":"Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil","volume":"7","author":"Schmidt","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026063004402422000_9.1.240.38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pcd.2016.07.006","article-title":"Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population","volume":"10","author":"Nakagami","year":"2016","journal-title":"Prim Care Diabetes"},{"key":"2026063004402422000_9.1.240.39","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7486493","article-title":"HbA1c Cutoff Point of 5.9% Better Identifies High Risk of Progression to Diabetes among Chinese Adults: Results from a Retrospective Cohort Study","volume":"2018","author":"Liang","year":"2018","journal-title":"J Diabetes Res"},{"key":"2026063004402422000_9.1.240.40","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820928844","article-title":"Incidence and risk factors of type 2 diabetes mellitus in individuals with different fasting plasma glucose levels","volume":"11","author":"Han","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026063004402422000_9.1.240.41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmjdrc-2020-001529","article-title":"Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria","volume":"8","author":"van Herpt","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026063004402422000_9.1.240.42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3349\/ymj.2008.49.2.217","article-title":"The effect of lowering the threshold for diagnosis of impaired fasting glucose","volume":"49","author":"Kim","year":"2008","journal-title":"Yonsei Med J"},{"key":"2026063004402422000_9.1.240.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03686.x"},{"key":"2026063004402422000_9.1.240.44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2009.11.001","article-title":"Hemoglobin A1c in predicting progression to diabetes","volume":"87","author":"Nakagami","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.10.014"},{"key":"2026063004402422000_9.1.240.46","doi-asserted-by":"crossref","first-page":"110829","DOI":"10.1016\/j.diabres.2023.110829","article-title":"HbA1c-defined prediabetes and progression to type 2 diabetes in Denmark: A population-based study based on routine clinical care laboratory data","volume":"203","author":"Nicolaisen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026063004402422000_9.1.240.47","article-title":"Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia","volume":"10","author":"Richter","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026063004402422000_9.1.240.48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000794","article-title":"Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes","volume":"7","author":"Lee","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026063004402422000_9.1.240.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2902-4"}],"container-title":["BMJ Nutrition, Prevention &amp; Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjnph-2024-000877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:18:49Z","timestamp":1782821929000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutrition.bmj.com\/lookup\/doi\/10.1136\/bmjnph-2024-000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjnph-2024-000877"],"URL":"https:\/\/doi.org\/10.1136\/bmjnph-2024-000877","relation":{},"ISSN":["2516-5542"],"issn-type":[{"value":"2516-5542","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}